doi.org/10.1016/s0140-6736(21)00592-4

Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial

..., Kihyun Kım
53
The Lancet88.50
Volume: 397, Issue: 10292, Pages: 2361 - 2371
Published: Jun 1, 2021
Paper Fields
Paper Details
Title
Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial
DOI
doi.org/10.1016/s0140-6736(21)00592-4
Published Date
Jun 1, 2021
Journal
The Lancet
Volume
397
Issue
10292
Pages
2361 - 2371
© 2025 Pluto Labs All rights reserved.